• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharma Advanced Research Company Limited — Updates, 03-02-2026: Press Release

    03-02-2026 | 08:35 am

    SPARC secured a Rare Pediatric Disease Priority Review Voucher (PRV) from the FDA for Sezaby® approval. This tradable PRV offers strategic flexibility, accelerating SPARC's pipeline development to bring new therapies to patients faster, addressing unmet medical needs.

    No comments yet. Be the first to comment!

    All announcements from Sun Pharma Advanced Research Company Limited